STOCK TITAN

Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Abbott (NYSE: ABT) has launched Similac 360 Total Care, the first U.S. infant formula featuring a unique blend of five human milk oligosaccharides (HMOs) to support overall baby health, immune system, and brain development. This formula addresses the needs of the nearly 75% of parents using infant formula within the first six months due to various reasons. With over 20 years of research on HMOs, Abbott aims to narrow the gap between breast milk and formula, offering parents a scientifically backed alternative to nourish their babies.

Positive
  • Launch of Similac 360 Total Care with five HMOs enhances product offering in the infant formula market.
  • Addresses the nutritional needs of approximately 75% of parents who use infant formula.
Negative
  • None.

ABBOTT PARK, Ill., Nov. 16, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of Similac 360 Total Care, the company's next generation of infant formula with HMOs, major prebiotics structurally identical to those found in human breast milk. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby's health and development, including the developing immune system, digestive system and brain.

Abbott scientists have been studying HMOs in breast milk for more than two decades. While breast milk is the gold standard of infant nutrition, nearly 75% of parents introduce infant formula within the first six months of a baby's life for a variety of reasons. Abbott supports parents, whatever their feeding choice. Now with the introduction of Similac 360 Total Care, parents can use a formula with a blend of five specific HMOs, previously only available to infants through breast milk.

"While nothing can replace the benefits of breast milk where HMOs are naturally abundant, some parents cannot or choose not to breastfeed, which makes infant formula the only suitable, nutritionally complete alternative for babies," said Rachael Buck, Ph.D., senior research fellow at Abbott. "Now, after delivering the first infant formula with HMOs in 2016, we are delivering our closest formula to breast milk ever, further working to narrow the gap between breast milk and formula so we can give babies the building blocks they need to learn, grow and thrive."

The introduction of Similac 360 Total Care is part of Abbott's ongoing commitment to support health from infancy onward. Through ongoing research, investment and innovation, this commitment supports Similac's Promises Project, the promise to support all parents regardless of their feeding choices.

"Parents strive to make the best decisions for their children every day," said Shawn Millerick, vice president of Pediatric Nutrition at Abbott. "We have made a promise to parents to provide them with our very best, scientifically-backed products like Similac 360 Total Care, as well as resources and information to support them and their feeding choices."

Similac 360 Total Care will be available online at www.AbbottStore.com, and at major retailers online and in-store locations, including Amazon, Walmart and Target. For more information on the science of Similac 360 Total Care and support for parents, visit Similac.com.  

About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at http://www.facebook.com/Abbott and on Twitter @AbbottNews.

1 HMOs in Similac 360 Total Care are not from human milk
2 The five specific HMOs include 2'-FL, 3-FL, 3'-SL,  6'- SL, and LNT across fucosylated, sialylated and acetylated categories of HMOs.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbott-launches-similac-360-total-care-with-exclusive-blend-of-five-hmo-prebiotics-and-designed-to-support-the-immune-system-digestive-health-and-brain-development-301425834.html

SOURCE Abbott

FAQ

What is Similac 360 Total Care launched by Abbott?

Similac 360 Total Care is Abbott's first infant formula in the U.S. featuring a unique blend of five human milk oligosaccharides (HMOs) designed to support infant health, immune function, and brain development.

When was Similac 360 Total Care launched?

Similac 360 Total Care was launched on November 16, 2021.

What are the benefits of HMOs in Similac 360 Total Care?

HMOs in Similac 360 Total Care support the immune system, digestive health, and brain development, providing a nutritional profile closer to that of breast milk.

Where can I purchase Similac 360 Total Care?

Similac 360 Total Care is available online at www.AbbottStore.com and at major retailers, including Amazon, Walmart, and Target.

Abbott Laboratories

NYSE:ABT

ABT Rankings

ABT Latest News

ABT Stock Data

200.24B
1.73B
0.53%
78.64%
0.81%
Medical Devices
Pharmaceutical Preparations
Link
United States of America
ABBOTT PARK